Kalbe Farma Tbk vs Kian Santang Muliatama Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 312.28B, 7.8M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 105.7× Kian Santang Muliatama Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 7.8M). Which is the better fit depends on your goals.
| KLBF | RGAS | |
|---|---|---|
Market Cap | 33T | 312.28B |
Volume | 98.44M | 7.8M |
Lot | 984.38K | 77.95K |
Turnover | 70.64B | 1.64B |
Average Price | 717.58 | 210.89 |
Value | 70.64B | 1.64B |
Indicative Equilibrium Price | 720 | 214 |
Indicative Equilibrium Volume | 43.62K | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →